Led strategies and positions on health and medicines (cost containment, intellectual property, pricing, regulatory) aligned with corporate. Led institutional relations with national and European stakeholders: industry & trade associations, scientific societies, patient organizations and NGO’s. Ensured coordination of communication strategies, (internal, corporate, commercial, crisis management).As market access leader, coordinated reimbursement and access to Novartis medicines (input into development, evidence generation, reimbursement, market introduction, value demonstration, account management, tenders, pricing). Portfolio >€150 million include diabetes, hypertension, heart failure, COPD, asthma, Alzheimers' , multiple sclerosis, retina and glaucoma, infection, osteoporosis, vaccines, transplantation, auto-immune disorders. Since 2007, reimbursed >20 new medicines. 24 persons under direct responsibility.Results: launched value based healthcare debate in Portugal; conference with Prof. Michael Porter (HBS) followed by discussion with Ministry of Health re. next steps (2011). Organized inauguration of Novartis offices (2012) with participation of Portuguese President and Ministers of Economy, Science and Health. Scaled up health economics & evidence generation team resulting in >30 top publications/year and communications in leading scientific conferences (best practice). Implemented 1st-in-kind access models in Portugal incl. discount programs, pricing per indication and outcomes based agreements. Coordinated Pharma task forces on health technology assessments, and EFPIA/APIFARMA conference on Value & Innovation (Portuguese Presidency of EU 021) endorsing high level forum (HLF) on Access & Affordability.

Novartis Administrator until Feb 2019 and member of the Country Executive Committee until 2021. Responsible to coordinate Novartis groups' positions and internal/external practices. Coordinated high level Novartis group institutional presence in Portugal (incl. Novartis Pharma, Novartis Oncology, Novartis Gene therapies, Sandoz, and Alcon). Responsible for clearance and compliance oversight for grants, sponsorship and awards, and selected commercial activities. Ensured cross divisional alignment on Public Affairs and Access groups (team coordinator/leader). Team won the EU Public Affairs award in 2020.

Develop and coordinated media strategy supporting corporate captainship in cardiovascular area, elevating public recognition of key healthcare initiatives (Consigo no Coração and Valsim) supporting growth strategies. Prepared next wave of hi profile opinion leaders and train them as spokespersons. Persons under direct responsibility: 2

Managed Pfizer/Pharmacia merger activities (communications and stakeholder relations), minimizing impact of restructuring. Developed strategies & actions to boost company reputation, broaden stakeholder relations and advance Pfizer agenda: annual Pfizer Science award (with Sociedade Ciências Médicas), fight overuse of antibiotics (with Directorate General of Health), risk behaviors in adolescents (with Ministry of Education) annual Pfizer Science forum. Created 2 corporate publications on Healthy Ageing ("Idade Maior") and The Pfizer Journal (local adaptation). Created first in industry team dedicated team to patient engagement. Managed crisis situation (Cox2 inhibitors withdrawal). Developed the local adaptation of the new corporate branding. (4 persons under direct responsibility)

Coordinated development and implementation of strategies and positions in key corporate and healthcare topics. Managed institutional relations with scientific societies and professional organizations. Organised the 1st regular forum for Science Journalists. Established processes and internal training for crisis management. Continued coordination of Web portal strategy, events management and PR / media coordination. (6 persons under direct responsibility).

Managed scientific events team (4 persons) responsible for organizing 50-60 national and regional scientific events in 8 therapeutic areas per year. Prepared strategy, content management and launched the 1st pharma web portal in Portugal fully dedicated to healthcare professionals based on Yahoo! partnership (UK). Responsible for management of media relations, coordinating annual advertising budget (lay and specialized press) and PR programs. (4 persons under direct responsibility)

Launched 1st causal treatment for prostate enlargement (BPH) (>30% budget over achievement in 1st year sales), consecutive over achievement in years 2 and 3 (both top line as well as profitability). Managed the hepatitis B vaccine (>80% over achievement in 1st year) and oral antibiotics (quinolone) for urinary and GI infections, annual sales on target, while substantially improving bottom line (by reducing promotional effort to adjust to seasonality demand.

Managed market research for neurosciences, cardiovascular, respiratory and antibiotics portfolio. Responsible for segmentation and targeting and performance dashboards on commercial excellence and sales performance. Member of launch teams in asthma, hypertension and cholesterol. Organised the annual worldwide event of market research heads in Portugal. Supported local implementation of the first 2 health economics studies ever conducted in Portugal (cost/effectiveness of ace inhibitors in hypertension, cost/effectiveness of statins in cholesterol management). Implemented innovative strategies on commercial information systems (e.g 1st Geographic information system for regional sales analysis, EMR eletronic marker recognition for fast data acquisition)

(military service).After military training, served as finances officer (military administration specialty) in the finance / accounting department of Infantry Army in Faro HQ (south of Portugal).

Internship at Pricing & Contracts department, securing management of customer dabase, invoicing, preparation of financial proposals (long term leasing) & contract management.

Internship at IT department of Quimigal (former industrial arm of CUF) on programming languages and operating systems, with development of a software application for invoicing.